Stocktoria
Sagimet Biosciences Inc. SGMT
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2023-07-14
Sagimet Biosciences Inc. statistics & valuation
Market cap$432.0M
P / B3.9×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Operating margin | — | — | -1537.0% | — |
| Net margin | — | — | -1393.8% | — |
| Return on assets | -43.8% | -28.4% | -28.8% | -92.3% |
| Return on equity | -45.8% | -29.2% | -30.6% | 16.3% |
| Current ratio | 22.82 | 34.30 | 17.09 | 6.21 |
Source: SEC EDGAR filings · CIK 0001400118 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.